GUILLERMO GARCIA-MANERO to Hematology
This is a "connection" page, showing publications GUILLERMO GARCIA-MANERO has written about Hematology.
Connection Strength
3.387
-
Highlights in myelodysplastic syndromes from the 62nd American Society of Hematology Annual Meeting and Exposition: commentary. Clin Adv Hematol Oncol. 2021 Jan; 19 Suppl 5(1):20-23.
Score: 0.699
-
Highlights in myelodysplastic syndromes from the 2020 American Society of Clinical Oncology Annual Meeting and the 25th European Hematology Association Congress: commentary. Clin Adv Hematol Oncol. 2020 Sep; 18 Suppl 14(9):20-23.
Score: 0.683
-
Highlights in myelodysplastic syndromes from the 61st American Society of Hematology Annual Meeting: commentary. Clin Adv Hematol Oncol. 2020 Feb; 18 Suppl 5(2):18-22.
Score: 0.656
-
Highlights in Myelodysplastic Syndromes From the 60th American Society of Hematology Annual Meeting: Commentary. Clin Adv Hematol Oncol. 2019 02; 17 Suppl 5(2):16-19.
Score: 0.612
-
Recent Advances in the Treatment of MDS. A review of selected presentations from the 48th Annual Meeting of the American Society of Hematology, December 9-12, 2006, Orlando, Florida. Clin Adv Hematol Oncol. 2007 Mar; 5(3 Suppl 6):1-13; quiz 15-6.
Score: 0.268
-
Consensus proposal for revised International Working Group 2023 response criteria for higher-risk myelodysplastic syndromes. Blood. 2023 04 27; 141(17):2047-2061.
Score: 0.205
-
Proposals for revised IWG 2018 hematological response criteria in patients with MDS included in clinical trials. Blood. 2019 03 07; 133(10):1020-1030.
Score: 0.150
-
An international consortium proposal of uniform response criteria for myelodysplastic/myeloproliferative neoplasms (MDS/MPN) in adults. Blood. 2015 Mar 19; 125(12):1857-65.
Score: 0.116